Catalyst Wire Dossier Catalyst Wire Dossier

Implantable cardioverter-defibrillator with antitachycardia pacing (ATP)

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Implantable cardioverter-defibrillator with antitachycardia pacing (ATP), covering 2024-10-22 to 2024-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP [NA]

See pricing